Yakushi Technology: Announcement on the allocation of equity and adjustment of convertible debt-to-stock conversion prices in 2022
Jun 5, 2023 07:02 ET
Yakushi Technology: An indicative announcement that Yakushi convertible bonds may trigger a downward revision of the conversion price conditions
May 31, 2023 03:38 ET
Yakushi Technology: An indicative announcement that Yakushi convertible bonds may trigger a downward revision of the conversion price conditions
May 10, 2023 04:26 ET
Yakushi Technology: An indicative announcement that Yakushi convertible bonds may trigger a downward revision of the conversion price conditions
Dec 22, 2022 02:38 ET
Yakushi Technology: 2021 Annual Equity Distribution Implementation Notice
Jun 6, 2022 07:08 ET
Pharmaceutical Technology: Announcement on the acquisition of 46.07% of the shares of Zhejiang Huishi Pharmaceutical Co., Ltd. to complete the industrial and commercial changes
May 27, 2022 03:50 ET
Yakushi Technology: Prospectus Notice for Issuance of Convertible Corporate Bonds to Unspecified Targets
Apr 17, 2022 12:00 ET
Yakushi Technology: Online Roadshow Announcement on Issuance of Convertible Corporate Bonds to Unspecified Targets
Apr 17, 2022 12:00 ET
Pharmaceutical Stone Technology: 1. Responses from issuers and sponsors to the implementation letter of feedback on the issuance registration process (revised draft)
Mar 9, 2022 11:00 ET
Medicinal Stone Technology: 3 Supplemental Legal Opinions (4)
Mar 9, 2022 11:00 ET
Pharmaceutical Stone Technology: 2 Accountants' Response to the Issuance and Registration Process Feedback Implementation Letter
Mar 9, 2022 11:00 ET
Pharmaceutical Stone Technology: Responses from issuers and sponsors to the implementation letter of feedback on the issuance registration process (revised draft)
Mar 9, 2022 05:56 ET
Pharmaceutical Stone Technology: Prompt Notice on Responding to the “Issuance and Registration Process Feedback Implementation Letter”
Mar 9, 2022 05:56 ET
Medicinal Stone Technology: Issuance and Registration Process Feedback Implementation Letter
Jan 11, 2022 11:00 ET
Pharmaceutical Stone Technology: Announcement on the application for issuing convertible corporate bonds to unspecified targets and approved by the Shenzhen Stock Exchange GEM Listing Committee
Nov 25, 2021 22:46 ET
Medicinal Stone Technology: Application Guide (Second Revised Draft)
Nov 9, 2021 18:41 ET
Yakushi Technology: IPO Sponsorship Letter
Nov 9, 2021 18:41 ET
Yakushi Technology: Securities Issuance Sponsorship
Nov 9, 2021 18:41 ET
Pharmaceutical Stone Technology: Response of Nanjing Pharmaceutical Stone Technology Co., Ltd. and Huatai United Securities Co., Ltd. on the review inquiry letter of Nanjing Pharmaceutical Stone Technology Co., Ltd.'s application to issue convertible corpo
Nov 9, 2021 18:41 ET
Pharmaceutical Stone Technology: Prompt Notice on Response to the Audit Inquiry Letter on the Application for Issuance of Convertible Corporate Bonds to Unspecified Targets (Second Revised Draft)
Nov 9, 2021 18:41 ET
No Data
No Data